106 related articles for article (PubMed ID: 31570284)
1. Somatic mutations of candidate tumor suppressor genes folliculin-interacting proteins FNIP1 and FNIP2 in gastric and colon cancers.
Mo HY; Son HJ; Choi EJ; Yoo NJ; An CH; Lee SH
Pathol Res Pract; 2019 Nov; 215(11):152646. PubMed ID: 31570284
[No Abstract] [Full Text] [Related]
2. Folliculin-interacting proteins Fnip1 and Fnip2 play critical roles in kidney tumor suppression in cooperation with Flcn.
Hasumi H; Baba M; Hasumi Y; Lang M; Huang Y; Oh HF; Matsuo M; Merino MJ; Yao M; Ito Y; Furuya M; Iribe Y; Kodama T; Southon E; Tessarollo L; Nagashima K; Haines DC; Linehan WM; Schmidt LS
Proc Natl Acad Sci U S A; 2015 Mar; 112(13):E1624-31. PubMed ID: 25775561
[TBL] [Abstract][Full Text] [Related]
3. Identification and characterization of a novel folliculin-interacting protein FNIP2.
Hasumi H; Baba M; Hong SB; Hasumi Y; Huang Y; Yao M; Valera VA; Linehan WM; Schmidt LS
Gene; 2008 May; 415(1-2):60-7. PubMed ID: 18403135
[TBL] [Abstract][Full Text] [Related]
4. Interaction of folliculin (Birt-Hogg-Dubé gene product) with a novel Fnip1-like (FnipL/Fnip2) protein.
Takagi Y; Kobayashi T; Shiono M; Wang L; Piao X; Sun G; Zhang D; Abe M; Hagiwara Y; Takahashi K; Hino O
Oncogene; 2008 Sep; 27(40):5339-47. PubMed ID: 18663353
[TBL] [Abstract][Full Text] [Related]
5. Mutation of Fnip1 is associated with B-cell deficiency, cardiomyopathy, and elevated AMPK activity.
Siggs OM; Stockenhuber A; Deobagkar-Lele M; Bull KR; Crockford TL; Kingston BL; Crawford G; Anzilotti C; Steeples V; Ghaffari S; Czibik G; Bellahcene M; Watkins H; Ashrafian H; Davies B; Woods A; Carling D; Yavari A; Beutler B; Cornall RJ
Proc Natl Acad Sci U S A; 2016 Jun; 113(26):E3706-15. PubMed ID: 27303042
[TBL] [Abstract][Full Text] [Related]
6. Birt-Hogg-Dubé syndrome: Clinical and molecular aspects of recently identified kidney cancer syndrome.
Hasumi H; Baba M; Hasumi Y; Furuya M; Yao M
Int J Urol; 2016 Mar; 23(3):204-10. PubMed ID: 26608100
[TBL] [Abstract][Full Text] [Related]
7. Nutrient-induced FNIP degradation by SCFβ-TRCP regulates FLCN complex localization and promotes renal cancer progression.
Nagashima K; Fukushima H; Shimizu K; Yamada A; Hidaka M; Hasumi H; Ikebe T; Fukumoto S; Okabe K; Inuzuka H
Oncotarget; 2017 Feb; 8(6):9947-9960. PubMed ID: 28039480
[TBL] [Abstract][Full Text] [Related]
8. Folliculin encoded by the BHD gene interacts with a binding protein, FNIP1, and AMPK, and is involved in AMPK and mTOR signaling.
Baba M; Hong SB; Sharma N; Warren MB; Nickerson ML; Iwamatsu A; Esposito D; Gillette WK; Hopkins RF; Hartley JL; Furihata M; Oishi S; Zhen W; Burke TR; Linehan WM; Schmidt LS; Zbar B
Proc Natl Acad Sci U S A; 2006 Oct; 103(42):15552-7. PubMed ID: 17028174
[TBL] [Abstract][Full Text] [Related]
9. Intratumoral heterogeneity of FLCN somatic mutations in gastric and colorectal cancers.
Son HJ; Choi EJ; Yoo NJ; Lee SH
Pathol Oncol Res; 2020 Oct; 26(4):2811-2812. PubMed ID: 31709497
[No Abstract] [Full Text] [Related]
10. The role of the Deleted Colon Cancer (DCC) gene in colorectal and gastric cancer.
O'Boyle K
Cancer Invest; 2003 Jun; 21(3):484-5. PubMed ID: 12901294
[No Abstract] [Full Text] [Related]
11. Inactivating Frameshift Mutations of HACD4 and TCP10L Tumor Suppressor Genes in Colorectal and Gastric Cancers.
Jo YS; Kim MS; Yoo NJ; Lee SH
Pathol Oncol Res; 2020 Jan; 26(1):583-584. PubMed ID: 29532408
[No Abstract] [Full Text] [Related]
12. KAI1 COOH-terminal interacting tetraspanin (KITENIN), a member of the tetraspanin family, interacts with KAI1, a tumor metastasis suppressor, and enhances metastasis of cancer.
Lee JH; Park SR; Chay KO; Seo YW; Kook H; Ahn KY; Kim YJ; Kim KK
Cancer Res; 2004 Jun; 64(12):4235-43. PubMed ID: 15205336
[TBL] [Abstract][Full Text] [Related]
13. Frameshift mutations of a tumor suppressor gene ZNF292 in gastric and colorectal cancers with high microsatellite instability.
Lee JH; Song SY; Kim MS; Yoo NJ; Lee SH
APMIS; 2016 Jul; 124(7):556-60. PubMed ID: 27150435
[TBL] [Abstract][Full Text] [Related]
14. Frameshift mutation of a tumor suppressor gene PALB2 in gastric and colorectal cancers with microsatellite instability.
Kim MS; Lee SH; Yoo NJ; Lee SH
APMIS; 2013 Oct; 121(10):1015-6. PubMed ID: 23758548
[No Abstract] [Full Text] [Related]
15. Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype.
Rampino N; Yamamoto H; Ionov Y; Li Y; Sawai H; Reed JC; Perucho M
Science; 1997 Feb; 275(5302):967-9. PubMed ID: 9020077
[TBL] [Abstract][Full Text] [Related]
16. Novel recurrently mutated genes in African American colon cancers.
Guda K; Veigl ML; Varadan V; Nosrati A; Ravi L; Lutterbaugh J; Beard L; Willson JK; Sedwick WD; Wang ZJ; Molyneaux N; Miron A; Adams MD; Elston RC; Markowitz SD; Willis JE
Proc Natl Acad Sci U S A; 2015 Jan; 112(4):1149-54. PubMed ID: 25583493
[TBL] [Abstract][Full Text] [Related]
17. Birt-Hogg-Dubé (BHD) gene mutations in human gastric cancer with high frequency microsatellite instability.
Jiang W; Fujii H; Matsumoto T; Ohtsuji N; Tsurumaru M; Hino O
Cancer Lett; 2007 Apr; 248(1):103-11. PubMed ID: 16870330
[TBL] [Abstract][Full Text] [Related]
18. Frameshift somatic mutations in gastrointestinal cancer of the microsatellite mutator phenotype.
Yamamoto H; Sawai H; Perucho M
Cancer Res; 1997 Oct; 57(19):4420-6. PubMed ID: 9331106
[TBL] [Abstract][Full Text] [Related]
19. BRAF mutations in colon cancer are not likely attributable to defective DNA mismatch repair.
Wang L; Cunningham JM; Winters JL; Guenther JC; French AJ; Boardman LA; Burgart LJ; McDonnell SK; Schaid DJ; Thibodeau SN
Cancer Res; 2003 Sep; 63(17):5209-12. PubMed ID: 14500346
[TBL] [Abstract][Full Text] [Related]
20. KRAS mutations in traditional serrated adenomas from Korea herald an aggressive phenotype.
Kim KM; Lee EJ; Kim YH; Chang DK; Odze RD
Am J Surg Pathol; 2010 May; 34(5):667-75. PubMed ID: 20305537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
